首页 | 本学科首页   官方微博 | 高级检索  
     

肝素诱导的血小板减少症患者体外循环抗凝管理
引用本文:周伯颐. 肝素诱导的血小板减少症患者体外循环抗凝管理[J]. 中国胸心血管外科临床杂志, 2012, 19(5): 559-562
作者姓名:周伯颐
作者单位:中国医学科学院北京协和医学院阜外心血管病医院心血管病研究所体外循环科,北京,100037
摘    要:肝素诱导的血小板减少症患者预后差,病死率高,大大增加了体外循环手术的风险。对其早期诊断和选择一种安全有效的药物替代肝素抗凝是这类患者接受体外循环手术的关键。我们对肝素诱导的血小板减少症发病机制、实验室检查、诊断以及体外循环抗凝管理进行综述。

关 键 词:肝素诱导的血小板减少症  体外循环  抗凝

Anticoagulation Management in Patients with Heparin-induced Thrombocytopenia Undergoing Extracorporeal Circulation
ZHOU Bo-yi. Anticoagulation Management in Patients with Heparin-induced Thrombocytopenia Undergoing Extracorporeal Circulation[J]. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2012, 19(5): 559-562
Authors:ZHOU Bo-yi
Affiliation:.(Department of Extracorporeal Circulation,Cardiovascular Institute,Fu Wai Hospial,Peking Union Medical College&Chinese Academy of Medical Science,Beijing 100037,P.R.China)
Abstract:Patients with heparin-induced thrombocytopenia have a poor prognosis and high mortality,thus surgical risk under extracorporeal circulation increased.Early diagnosis,safe and effective alternative anticoagulation strategy are crucial for these patients to receive extracorporeal circulation surgery.This review focuses on the pathophysiology,laboratory examination,diagnosis and alternative anticoagulation strategy of extracorporeal circulation for patients with heparin-induced thrombocytopenia.
Keywords:Heparin-induced thrombocytopenia  Extracorporeal circulation  Anticoagulation
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号